Predictive Genetic Testing And Consumer Genomics Market Report 2026

Predictive Genetic Testing And Consumer Genomics Market Overview

• Predictive Genetic Testing And Consumer Genomics market size has reached to $9.07 billion in 2025 • Expected to grow to $18.61 billion in 2030 at a compound annual growth rate (CAGR) of 15.4% • Growth Driver: Impact Of Rising Personalized Medicine Awareness On The Market Growth Due To Increasing Demand For Tailored Healthcare Solutions • Market Trend: Revolutionizing Genomic Sequencing with High-Throughput, Cost-Efficient Technology • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Predictive Genetic Testing And Consumer Genomics Market?

Predictive genetic testing and consumer genomics refer to the analysis of an individual's deoxyribonucleic acid (DNA) to assess their risk of developing certain genetic conditions or traits and to provide personalized health, ancestry, and lifestyle insights. These services are typically offered directly to consumers or through healthcare providers, using genetic information to inform preventive health decisions or personal interest in genetic heritage. The main testing types of predictive genetic testing and consumer genomics are diagnostic testing, predictive testing, pharmacogenomic testing, and carrier screening. Diagnostic testing helps confirm or rule out genetic conditions in individuals who are already showing symptoms. The various technologies used include polymerase chain reaction (PCR), next-generation sequencing (NGS), microarray technology, and DNA sequencing. The varied service types offered include genetic counseling, sample collection and analysis, and the interpretation and reporting of genetic data. The different applications span across breast and ovarian cancer, cardiovascular screening, diabetic screening and monitoring, colon cancer, parkinsonism or alzheimer’s disease, urologic screening or prostate cancer screening, orthopedic and musculoskeletal, other cancer screening, and other diseases. The main end users include healthcare providers, research bodies, diagnostic labs, and consumers (direct-to-consumer testing).

What Is The Predictive Genetic Testing And Consumer Genomics Market Growth Forecast?

The predictive genetic testing and consumer genomics market size is expected to see rapid growth in the next few years. It will grow to $18.61 billion in 2030 at a compound annual growth rate (CAGR) of 15.4%. The growth in the forecast period can be attributed to increasing demand for personalized preventive healthcare, rising adoption of pharmacogenomic testing, expansion of consumer genomics platforms, growing integration with digital health apps, increasing regulatory oversight on genetic data usage. Major trends in the forecast period include increasing adoption of direct-to-consumer genetic testing, rising use of digital health platforms, growing demand for preventive health insights, expansion of at-home sample collection kits, enhanced focus on data privacy and security.

Global Predictive Genetic Testing And Consumer Genomics Market Segmentation

1) By Testing Type: Diagnostic Testing, Predictive Testing, Pharmacogenomic Testing, Carrier Screening 2) By Technology: Polymerase Chain Reaction (PCR), Next-Generation Sequencing (NGS), Microarray Technology, DNA Sequencing 3) By Service Type: Genetic Counseling Services, Sample Collection And Analysis, Data Interpretation And Reporting 4) By Application: Breast And Ovarian Cancer, Cardiovascular Screening, Diabetic Screening And Monitoring, Colon Cancer, Parkinsonism Or Alzheimer’s Disease, Urologic Screening Or Prostate Cancer Screening, Orthopedic And Musculoskeletal, Other Cancer Screening, Other Diseases 5) By End User: Healthcare Providers, Research Institutions, Diagnostic Laboratories, Consumers (Direct-to-Consumer Testing) Subsegments: 1) By Diagnostic Testing: Cancer Diagnostic Testing, Neurological Disorder Testing, Rare Disease Diagnostics 2) By Predictive Testing: Cancer Risk Prediction, Cardiovascular Disease Risk, Neurodegenerative Disorder Risk 3) By Pharmacogenomic Testing: Adverse Drug Reaction Prediction, Psychiatric Medication Response, Dosage Optimization 4) By Carrier Screening: Cystic Fibrosis Carrier Screening, Sickle Cell Anemia Carrier Screening, Tay-Sachs Carrier Screening

What Is The Driver Of The Predictive Genetic Testing And Consumer Genomics Market?

The rising awareness about personalized medicine is expected to propel the growth of the predictive genetic testing and consumer genomics market going forward. Personalized medicine refers to a medical approach that customizes treatment and prevention strategies based on an individual’s genetic profile, lifestyle, and environmental factors. The awareness about personalized medicine is growing because it improves treatment effectiveness by matching therapies to a patient’s unique biological characteristics. Predictive genetic testing and consumer genomics help personalized medicine by identifying genetic risks and traits, enabling tailored prevention, early diagnosis, and treatment strategies based on an individual’s genetic profile. For instance, in February 2024, according to the Personalized Medicine Coalition, a US-based professional membership organization, the Food and Drug Administration (FDA) approved 16 new personalized medicines in 2023, indicating an increase from 6 in 2022. Therefore, the rising awareness about personalized medicine is driving the growth of the predictive genetic testing and consumer genomics industry.

Key Players In The Global Predictive Genetic Testing And Consumer Genomics Market

Major companies operating in the predictive genetic testing and consumer genomics market are Thermo Fisher Scientific Inc., Abbott Laboratories, Laboratory Corporation of America Holdings, Quest Diagnostics Incorporated, QIAGEN N.V., Ancestry.com, Myriad Genetics Inc., ARUP Laboratories, BGI Genomics Co. Ltd., Invitae Corporation, 23andMe Inc., Helix Inc., Color Health Inc., Mapmygenome India Ltd., Reliance Life Sciences, Dante Labs Inc., EasyDNA, Gene by Gene Ltd., Nebula Genomics Inc., Pathway Genomics Corporation

Global Predictive Genetic Testing And Consumer Genomics Market Trends and Insights

Major companies operating in the predictive genetic testing and consumer genomics market are focusing on technological innovation, such as high-throughput and cost-efficient sequencing to enable large-scale, accurate, and affordable genomic analysis. High-throughput and cost-efficient sequencing refers to processing a massive number of genomes quickly while reducing per-genome costs, making population-level testing feasible. For instance, in February 2024, Ultima Genomics Inc., a U.S.-based sequencing company, launched its UG 100 sequencing system along with ppmSeq extreme-accuracy mode, offering up to 6–8 billion reads per wafer with dual-wafer runs reaching about 4.8 Tb and expected run times under 14 hours. Designed with a wafer-based substrate and flexible reagent cartridges, the system supports an industry-leading ~$100-genome roadmap through reagent costs of roughly $2,000 per wafer. The ppmSeq mode enables Q60 SNV raw-read accuracy without additional workflow steps. With its combination of low reagent cost, high automation, and AI-driven variant calling, the UG 100 is positioned for broad applications across consumer genomics, population screening, clinical WGS, pharmacogenomics, and large-scale research. Overall, the platform delivers faster, more scalable, and more affordable genomic data generation than legacy NGS technologies.

What Are Latest Mergers And Acquisitions In The Predictive Genetic Testing And Consumer Genomics Market?

In April 2025, Illumina Inc., a US-based biotechnology company, partnered with Tempus AI Inc. to accelerate the clinical adoption of precision medicine by integrating advanced genomic artificial intelligence (AI) and multimodal data, making comprehensive molecular profiling a routine aspect of patient care across various disease areas. Tempus AI Inc. is a US-based health technology company that utilizes AI-driven genomic analysis to enhance predictive genetic testing and consumer genomics.

Regional Outlook

North America was the largest region in the predictive genetic testing and consumer genomics market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Predictive Genetic Testing And Consumer Genomics Market?

The predictive genetic testing and consumer genomics market includes revenues earned by entities by providing services such as disease risk assessment, carrier screening, and ancestry and ethnicity testing. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Predictive Genetic Testing And Consumer Genomics Market Report 2026?

The predictive genetic testing and consumer genomics market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the predictive genetic testing and consumer genomics industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.